Literature DB >> 8643107

Fine chemical modifications at N- and C-termini enhance peptide presentation to T cells by increasing the lifespan of both free and MHC-complexed peptides.

B Maillère1, G Mourier, M Hervé, A Ménez.   

Abstract

We investigated the effect of modifying the N- and/or C-termini of the snake toxin peptide 24-36 on its presentation to T cells. Acetylation at the N-terminus as well as amidation at the C-terminus enhanced the capacity of the peptide to activate T cells. Simultaneous modifications further increased the stimulating activity, the peptide becoming approximately 100-fold more potent than the unmodified peptide. Clearly, the introduced modifications increased the lifetime of the peptide free in solution, by decreasing its proteolytic degradation, during the T cell stimulation assays. Paradoxically, however, at similar concentrations of free peptides, the modified ones, especially those having an acetylated N-terminus, were much more active than the unmodified peptide, irrespective of the experimental conditions. These observations suggested that components other than protection from proteolytic degradation should be associated with the higher stimulating activities of the modified peptides. Accordingly, chasing experiments with APC revealed that acetylation at N-terminus caused a higher persistence of the peptides at APC surface. Together, our data indicate that (i) the T cell stimulating capacity of a peptide is associated with its lifespans in the free and MHC II bound states; and (ii) these lifespans can be greatly enhanced by introducing fine chemical modifications at N- and C-termini. These data may have some implications in designing more potent peptidic immunomodulators.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8643107     DOI: 10.1016/0161-5890(95)00103-4

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  5 in total

1.  Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37.

Authors:  Adam A Strömstedt; Mukesh Pasupuleti; Artur Schmidtchen; Martin Malmsten
Journal:  Antimicrob Agents Chemother       Date:  2008-11-24       Impact factor: 5.191

2.  Identification of an I-Ed-restricted T-cell epitope of Escherichia coli outer membrane protein F.

Authors:  Kristina M Williams; Elmer C Bigley
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

Review 3.  Immunoregulatory T cell epitope peptides: the new frontier in allergy therapy.

Authors:  S R Prickett; J M Rolland; R E O'Hehir
Journal:  Clin Exp Allergy       Date:  2015-06       Impact factor: 5.018

4.  Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S.

Authors:  Lukas Jac Hawinkels; Els Me Verdegaal; Tom J Harryvan; Marten Visser; Linda de Bruin; Léonie Plug; Lisa Griffioen; Arend Mulder; Peter A van Veelen; Gerbrand J van der Heden van Noort; Marlieke Lm Jongsma; Miranda H Meeuwsen; Emmanuel Jhj Wiertz; Saskia J Santegoets; James Ch Hardwick; Thorbald Van Hall; Jacques Neefjes; Sjoerd H Van der Burg
Journal:  J Immunother Cancer       Date:  2022-03       Impact factor: 13.751

Review 5.  T Cell Epitope Peptide Therapy for Allergic Diseases.

Authors:  Robyn E O'Hehir; Sara R Prickett; Jennifer M Rolland
Journal:  Curr Allergy Asthma Rep       Date:  2016-02       Impact factor: 4.806

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.